Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-26T20:28:03.517Z Has data issue: false hasContentIssue false
  • English
  • Français

Neural mechanisms of childhood-onset bipolar illness

Published online by Cambridge University Press:  18 September 2015

R.M. Post ,
G.S. Leverich ,
A.M. Speer ,
G. Xing  and
S.R.B. Weiss
R.M. Post*
Affiliation:
Biological Psychiatry Branch, Bethesda, U.S.A.
*
Biological Psychiatry Branch, 10 Center Drive MSC 1272, Bldg. 10, Room 3N212, Bethesda, MD 20892-1272, United States
Get access Rights & Permissions [Opens in a new window]

Abstract

Substantial evidence exists for a cohort effect (earlier onset and increased prevalence) for both unipolar and bipolar affective disorder in every generation born since World War II. This effect could be related to inherited mechanisms (e.g., bi-Hneal pedigrees or genetic anticipation) or to environmental/experiential effects on gene expression (e.g., stressor effects on the induction of transcription and growth factors, enzymes, hormones and their receptors, and signal transduction molecules) as documented in preclinical models of neonatal maternal separation.

This laboratory evidence is summarized and new clinical data on the impact of severe stressors on the unfolding course of bipolar illness are noted. The reported occurrence of childhood or adolescent physical or sexual abuse, compared to those who report their absence, is associated with: earlier bipolar illness onset; faster cycling (including ultradian) patterns; increased Axis I and II comorbidities; and increased time ill in a prospective year of follow-up. Selectively, physical abuse was associated with a reported pattern of increasingly severe mania and sexual abuse with increased numbers of serious suicide attempts.

In a retrospective survey of parents of children with an approximate average age of 13 who were diagnosed with bipolar illness (compared to those with other diagnoses and those with no diagnosis), a cluster of symptoms related to irritability and dyscontrol differentiated the bipolar children earliest. These symptoms included: temper tantrums, irritability, inattention, hyperactivity, impulsivity, poor frustration tolerance, and increased aggression.

Given the growing evidence that episodes of affective dysfunction can not only convey morbidity and mortality, but may also sensitize to further recurrence and thus change the course of illness, opportunities abound for early recognition and intervention in childhood onset bipolar illness. Such a successful endeavor would both allow a more normal psychobiological development and allow the possibility of preventing the unfolding of more full-blown bipolar illness altogether.

Keywords

bipolar disorderchildhoodadolescencegene expressionneurotrophic factorsapoptosismaniadepressionsuicidematernal deprivationsignal transductionphysical abuselithiumsexual abuseneuroprotectionneurogenesis
Type
Articles
Information
Acta Neuropsychiatrica , Volume 12 , Issue 3 , September 2000 , pp. 139 - 143
Copyright
Copyright © Scandinavian College of Neuropsychopharmacology 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Gershon, ES, Hamovit, JH, Guroff, JJ, Nurnberger, JI. Birth-cohort changes in manic and depressive disorders in relatives of bipolar and schizoaffective patients. Arch Gen Psychiatry 1987;44:314–319.CrossRefGoogle ScholarPubMed
2.Klerman, GL, Weissman, MM. Increasing rates of depression. JAMA 1989;261:2229–2235.CrossRefGoogle ScholarPubMed
3.Lasch, K, Weissman, M, Wickramaratne, P, Bruce, ML. Birth-cohort changes in the rates of mania. Psychiatr Res 1990;33:31–37.CrossRefGoogle ScholarPubMed
4.Kramlinger, KG, Post, RM. Ultra-rapid and ultradian cycling in bipolar affective illness. Br J Psychiatry 1996;168:314–323.CrossRefGoogle ScholarPubMed
5.Suppes, T, Leverich, GS, Keck, PE Jr., Nolen, W, Denicoff, KD, Alts-huler, LL, McElroy, SL, Rush, AJ, Kupka, R, Bickel, M, Post, RM. The Stanley Foundation Bipolar Treatment Outcome Network: II. Demographics and illness characteristics of the first 261 patients. J Affect Disord 2000; in press.Google Scholar
6.Frye, MA, Ketter, TA, Leverich, GS, Huggins, T, Lantz, C, Denicoff, KD, Post, RM. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000;61:9–15.CrossRefGoogle ScholarPubMed
7.Gelenberg, AJ. Kane, JM, Keller, MB, Lavori, P. Rosenbaum, JF. Cole, K, Lavelle, J. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Enul J Med 1989;321:1489–1493.CrossRefGoogle ScholarPubMed
8.O'Connell, RA, Mayo, JA, Flatow, L, Cuthbertson, B, O'Brien, BE. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991;159:123–129.CrossRefGoogle ScholarPubMed
9.Swann, AC, Bowden, CL, Calabrese, JR. Dilsaver, SC, Morris, DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry 1999;156:1264–1266.CrossRefGoogle ScholarPubMed
10.Brandt, J, Bylsma, FW, Gross, R, Stine, OCRanen, N, Ross, CA. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 1996;46:527–531.CrossRefGoogle ScholarPubMed
11.McInnis, MG, McMahon, FJ, Chase, GA, Simpson, SG, Ross, CA, De-Paulo, JR Jr.Anticipation in bipolar affective disorder. Am J Hum Genet 1993;53:385–390.Google ScholarPubMed
12.Mendlewicz, J, Lindbald, K, Souery, D, Mahieu, B. Nylander, PO, De Bruyn, A, Zander, C, Engstrom, C, Adolfsson, R. Van Broeckhoven, C. Schalling, M, Lipp, O. Expanded trinucleotide CAG repeats in families with bipolar affective disorder. Biol Psychiatry 1997;42:1115–1122.CrossRefGoogle ScholarPubMed
13.Craddock, N, McKeon, P, Moorhead, S, Guy, C, Harrison, D, Mynett-Johnson, L, Claffey, E, Feldman, E, McGuffin, P. Owen, MJ, O'Dono-van, MC. Expanded CAG/CTG repeats in bipolar disorder: no correlation with phenotypic measures of illness severity. Biol Psychiatry 1997;42:876–881.CrossRefGoogle ScholarPubMed
14.Abel, T, Nguyen, PV, Barad, M, Deuel, TA. Kandel, ER, Bourtchouladze, R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 1997;88:615–626.CrossRefGoogle ScholarPubMed
15.Post, RM, Weiss, SRB, Uhde, TW. Clark, M, Rosen, JB. Implications of cocaine kindling, induction of the proto-oncogene c-fos and contingent tolerance. In: Hoehn-Saric, R (ed). Biology of Anxiety Disorders. Washington, DC., APA Press, 1993. pp 121–175.Google Scholar
16.Smith, MA, Makino, S, Altemus, M, Michelson, D, Hong, SK, Kvetnansky, R, Post, RM. Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proc Natl Acad Sci USA 1995;92:8788–8792.CrossRefGoogle ScholarPubMed
17.Duman, RS, Heninger, GR. Nestler, EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597–606.CrossRefGoogle ScholarPubMed
18.Chen, RW, Chuang, DM. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 1999;274:6039–6042.CrossRefGoogle ScholarPubMed
19.Plotsky, PM, Meaney, MJ. Early, postnatal experience alters hypothalamic corticotropin-relcasing factor (CRF) mRNA. median eminence CRF content and stress-induced release in adult rats. Mol Brain Res 1993;18:195–200.CrossRefGoogle ScholarPubMed
20.Plotsky, PM, Eisler, JA. Anand, KJS. Long-term consequences of neonatal stress (abstract). Eur Neuropsychopharmacol 1996;6[suppl 3]: 217–217.CrossRefGoogle Scholar
21.Francis, DD, Caldji, C, Champagne, F. Plotsky, PM, Meancy, MJ. The role of corticotropin-releasing factor-norepinephrine systems in mediating the effects of early experience on the development of behavioral and endocrine responses to stress. Biol Psychiatry 1999;46:1153–1166.CrossRefGoogle ScholarPubMed
22.Meaney, MJ, Aitken, DH, Van Berkcl, C, Bhatnagar, S, Sapolsky, RM. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 1988;239(4841 Pt 1):766–768.CrossRefGoogle ScholarPubMed
23.Francis, D, Diorio, J, Liu, D, Meaney, MJ. Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 1999;286:1155–1158.CrossRefGoogle ScholarPubMed
24.Levine, S, Huchton, DM, Wiener, SG, Rosenfeld, P. Time course of the effect of maternal deprivation on the hypothalamic- pituitary-adrenal axis in the infant rat. Dev Psychobiol 1991;24:547–558.CrossRefGoogle ScholarPubMed
25.Xing, GQ, Smith, MA, Levine, S, Yang, ST, Post, RM, Zhang, LX. Suppression of CaMKII and nitric oxide synthase by maternal deprivation in the brain of rat pups. Society for Neuroscience Abstracts 24[Abstract 176.9], 452.1998.Google Scholar
26.Zhang, LX, Xing, GQ, Levine, S, Post, RM, Smith, MA. Effects of maternal deprivation on neurotrophic factors and apoptosis-related genes in rat pups. Society for Neuroscience Abstracts 24[Abstract 176.8], 451, 1998.Google Scholar
27.Zhang, LX, Xing, GQ, Levine, S, Post, RM, Smith, MA. Maternal deprivation induces neuronal death. Society for Neuroscience Abstracts 23[2], 1113, 1997.Google Scholar
28.Smith, MA, Zhang, LX, Dent, G, Zhan, Y, Post, RM, Levine, S. Maternal deprivation increases apoptosis in the infant rat brain. ACNP Abstracts, 1998.Google Scholar
29.Leverich, GS, Nolen, W, Rush, AJ, McElroy, SL, Keck, PE Jr., Denicoff, KD, Suppes, T, Altshuler, LL, Kupka, R. Kramlinger, KG, Post, RM. The Stanley Foundation Bipolar Treatment Outcome Network: I. Longitudinal methodology. J Affect Disord 2000; in press.Google Scholar
30.Leverich, GS. McElroy, SL, Suppes, T, Keck, PE Jr, Denicoff, KD, Nolen, WA. Altshuler, LL, Rush, AJ. Kupka, R, Frye, M, Autio, K, Post, RM. Early physical or sexual abuse and the course of bipolar illness. Am J Psychiatry 2000; in review.Google Scholar
31.First, MB. Spitzer, RL, Gibbon, M. Williams, JB. Structured Clinical Interview for DSM-IV Axis 1 Disorders - Patient Edition (Research Version, 2/96 final). 1996. New York, Biometrics Research Department, New York State Psychiatric Institute.Google Scholar
32.Hyler, S. Personality questionnaire with two additional research categories of personality disorders: The PDQ4+. 1994. New York, New York State Psychiatric Institute.Google Scholar
33.Antelman, SM. Eichler, AJ. Black, CA, Kocan, D. Interchangeability of stress and amphetamine in sensitization. Science 1980;207:329–331.CrossRefGoogle ScholarPubMed
34.Kalivas, PW, Duffy, P. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat. Biol Psychiatry 1989;25:913–928.CrossRefGoogle ScholarPubMed
35.Nestler, EJ. Kelz, MB, Chen, JD, Fos B: a molecular mediator of long-term neural and behavioral plasticity. Brain Res 1999;835:10–17.CrossRefGoogle Scholar
36.Post, RM. Weiss, SR. Ziskind-Somerfeld Research Award 1992. Endogenous biochemical abnormalities in affective illness: therapeutic versus pathogenic. Biol Psychiatry 1992;32:469–484.CrossRefGoogle ScholarPubMed
37.Post, RM. Weiss, SRB. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amvgdala-kindled seizures. Mol Neurobiol 1996;13:33–60.CrossRefGoogle ScholarPubMed
38.Weiss, SR. Clark, M. Rosen, JB. Smith, MA. Post, RM. Contingent tolerance to the anticonvulsant effects of carbamazepine: relationship to loss of endogenous adaptive mechanisms. Brain Res Brain Res Rev 1995;20:305–325.CrossRefGoogle Scholar
39.Duman, RS. Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 1998;44:324–335.CrossRefGoogle ScholarPubMed
40.Makino, S, Baker, RA, Smith, MA, Gold, PW. Differential regulation of neuropeptide Y mRNA expression in the arcuate nucleus and locus coeruleus by stress and antidepressants. J Neuroendocrinol 2000;12:387–395.CrossRefGoogle ScholarPubMed
41.Davis, JM, Wang, Z, Janicak, PG. A quantitative analysis of clinical drug trials for the treatment of affective disorders. Psychopharmacol Bull 1993;29:175–181.Google ScholarPubMed
42.Chuang, DM, Wei, H, Qin, Z, Wei, W, Wang, Y, Qian, Y. Lithium inhibits striatal damage in an animal model of Huntington's disease (abstract). Society for Neuroscience Abstracts 25 [Abstract #09611]. 1999.Google Scholar
43.Nonaka, S, Chuang, DM. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport 1998;9:2081–2084.CrossRefGoogle ScholarPubMed
44.Chen, G. Zeng, WZ, Yuan, PX. Huang, LD, Jiang, YM, Zhao, ZH, Manji, HK. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 1999;72:879–882.CrossRefGoogle ScholarPubMed
45.Moore, GJ, Bebchuk, JM, Chen, G, Seraji-Bozorgzad, N, Wilds, IB, Faulk, MW, Jolkovsky, L, Koch, S, Manji, HK. Lithium increases N-acetyl aspartate (NAA) in the human brain: in vivo evidence in support of lithium-induced CNS Bcl-2 increases? Abstracts of the 38th ACNP Annual Meeting. 1999.CrossRefGoogle Scholar
46.Chen, G, Manji, HK. Mood stabilizers increase neurogenesis and neurite outgrowth: implications for the long term treatment of manic-depressive illness. Abstracts of the 38th ACNP Annual Meeting. 1999.Google Scholar
47.Lish, JD, Dime-Meenan, S. Whybrow, PC, Price, RA. Hirschfeld, RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994;31:281–294.CrossRefGoogle ScholarPubMed